HBV

HBV

Hepatitis B virus, also known as HBV or Orthohepadnavirus, is a type of virus that belongs to the Hepadnaviridae family of viruses. Hepatitis B is brought on by the virus HBV. The ground squirrel hepatitis virus, the woodchuck hepatitis virus, and the woolly monkey hepatitis B virus are the other three species that make up the Orthohepadnavirus, of which the hepatitis B virus is the type species. The Hepadnaviridae family includes the genus as a member. Based on antigenic epitopes found on its envelope proteins, HBV is classified into four major serotypes (adr, adw, ayr, ayw), and eight genotypes (A-H) based on the genome's overall nucleotide sequence variation.The genotypes are used to track the evolution and spread of the virus because they have a distinct geographic distribution. The severity of the disease, the progression and propensity for complications, the response to treatment, and perhaps vaccination, are all impacted by genotype differences.

HBV related products

Structure Cat No. Product Name CAS No. Product Description
V52848 (-)-5′-Noraristeromycin 150132-22-2 (-)-5'-Noraristeromycin is an antiviral compound.
V54209 (5S,8R)-HBV-IN-10 2716907-15-0 (5S,8R)-HBV (hepatitis B virus)-IN-10 is an isomer of compound 6 (WO2021204258A1).
V52756 (Rac)-Tenofovir-d6 ((Rac)-GS 1278-d6; (Rac)-PMPA-d6) 1020719-94-1 (Rac)-Tenofovir-d6 is the deuterated racemate of Tenofovir.
V52509 2'-Deoxy-L-adenosine 14365-45-8 2'-Deoxy-L-adenosine is a synthetic, orally bioactive, modified oligodeoxyribonucleotide.
V30082 4,5-Dicaffeoylquinic acid 57378-72-0 4,5-Dicaffeoylquinic acid is a novel and potent hepatoprotective and anti-HBV effects.
V52490 5-O-(E)-p-Coumaroylquinic acid 5746-55-4 5-O-(E)-p-Coumaroylquinic acid, a quinic acid analogue, is a potent phytochemical agent against hepatitis B virus.
V3189 AB-423 1572510-80-5 AB-423,a member of the sulfamoylbenzamide (SBA) class, is a potent HBV (hepatitis B virus) capsidassembly inhibitor that inhibits HBV replication with EC50/EC90of 0.08-0.27 μM/0.33-1.32 μM in cells.
V85030 AB-452 2226178-35-2
V54191 AB-506 2245020-50-0 AB-506 is an orally bioactive inhibitor of HBV (hepatitis B virus) replication that targets the viral core protein.
V53361 AB-836 2445597-31-7 AB-836 is an orally bioactive HBV (hepatitis B virus) capsid inhibitor.
V52660 Adefovir-d4 (GS-0393-d4; PMEA-d4) 1190021-70-5 Adefovir-d4 is the deuterium labelled form of Adefovir.
V54206 Antiviral agent 38 2247932-38-1 antiviral compound 38 (compound 2.1-1) is a potent antiviral compound.
V24024 BA-53038B 2306195-65-1 BA-53038B (BA53038B)is a novel and potent Hepatitis B Virus Nucleocapsid Assembly Inhibitor, also calledHBV core protein allosteric modulator (CpAM).
V4177 BAY 41-4109 racemate 298708-79-9 BAY 41-4109 racemate is the racemic mixture of BAY 41-4109 which is a novel and potent inhibitor of human hepatitis B virus (HBV) with anIC50of 53 nM.
V4178 BAY-41-4109 (R-isomer) 298708-81-3 BAY 41-4109 is a novel and potent inhibitor of human hepatitis B virus (HBV) with anIC50of 53 nM.
V4199 Bayer 41-4109 S-enantiomer 476617-51-3 Bay 41-4109 S-isomer is the less active enantiomer of Bay 41-4109.
V83851 Bepirovirsen sodium (ISIS 505358 sodium) 2563929-84-8
V41537 Bulevirtide (Myrcludex B; MyrB) 2012558-47-1 Bulevirtide (Myrcludex B; MyrB; Hepcludex) is a first-in-class entry inhibitor approved as an antiviral medication for the treatment of chronic hepatitis D.
V86060 Catenulopyrizomicin A
V53036 Chamaechromone (Chamaechromone; Chamaechromone) 93413-00-4 Chamaechromone is a biflavonoid extracted from the roots of Thymeaceae plants.
Contact Us Back to top